Coagulation factors, including FVIII and other molecules involved in hemostasis, such as VWF, have been implicated in the progression of liver fibrosis, while factors such as ADAMTS13 have shown potential in reducing fibrogenesis. This evidence concerns the gene ADAMTS13 and Hepatic fibrosis.